Individualized homoeopathic treatment for people suffering from migraine and its effect on migraine-related disability

EFFECTIVENESS OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN THE TREATMENT OF MIGRAINE ASSESSED USING THE MIGRAINE DISABILITY ASSESSMENT TEST - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/099918

Enrollment

Registered

2025-12-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G43- Migraine

Interventions

Intervention1: Individualised homoeopathic medicine: Medicines will be prescibed based on the selected similimum from the selected Totality with selected dose. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Migraine without Aura Common Migraine Migraine with Aura Classic Migraine Patients willing to participate in the study and giving written informed consent

Exclusion criteria

Exclusion criteria: Patients with other chronic headache disorders Pregnant and other lactation ladies Patients with pathological conditions of Brain Immunocompromised patients

Design outcomes

Primary

Measure	Time frame
To understand the efficacy of individualised Homoeopathic medicine assessed with Change in Midas questionnaire score from baseline to 3 months post Treatment and improving the quality of life a patientTimepoint: Baseline and 3 months	—

Secondary

Measure	Time frame
Change in migraine frequency attacks of episodes of migraine from baseline to 3 months post intervention of homoeopathic TreatmentTimepoint: Baseline and 3 months	—

Countries

India

Contacts

Public ContactDr JANAKARAPALLE JAYAKRISHNA

JIMS Homoeopathic Medical College And Hospital

valli.kandada@gmail.com9848366620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026